Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes (T2D): Outcomes by Body Mass Index (BMI)

被引：0
|
作者：
Shatskov, Alla
Rezvani, Geoffrey
Mansfield, Traci
机构：
来源：
DIABETES | 2016年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1141-P
引用
收藏
页码：A299 / A299
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety of Dapagliflozin for Type 2 Diabetes Mellitus Patients With a History of Cardiovascular Disease
    Leiter, Lawrence A.
    Cefalu, William T.
    Debruin, Tjerk W.
    Gausenilsson, Ingrid
    Sugg, Jennifer
    Parikh, Shamik J.
    DIABETES, 2012, 61 : A287 - A287
  • [32] Efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus and concomitant heart failure
    Kosiborod, M.
    Gause-Nilsson, I.
    Sonesson, C.
    Johnsson, E.
    DIABETOLOGIA, 2015, 58 : S368 - S368
  • [33] Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India
    Varshney, Amit
    Rawat, Ramakant
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2023, 69 (08):
  • [34] Efficacy and Safety of Sitagliptin (SITA) Compared with Dapagliflozin (DAPA) in People ≥65 Years Old with T2D
    Raji, Annaswamy
    Xu, Zhi Jin
    Lam, Raymond L.
    Kaufman, Keith D.
    Engel, Samuel S.
    DIABETES, 2019, 68
  • [35] Mechanisms of the Antihyperglycemic Effect of Sitagliptin in Patients with Type 2 Diabetes (T2D)
    Muscelli, Elza
    Casolaro, Arturo
    Gastaldelli, Amalia
    Mari, Andrea
    Seghieri, Giuseppe
    Chen, Yu
    Alba, Maria
    Holst, Jens
    Ferrannini, Ele
    DIABETES, 2011, 60 : A267 - A267
  • [36] BODY MASS INDEX IN TYPE 2 DIABETES
    Tian, Y.
    Kimball, E.
    Kong, S.
    Bouchard, J.
    Huang, J.
    Hobbs, T.
    Sakurada, B.
    Weng, W.
    VALUE IN HEALTH, 2016, 19 (03) : A197 - A197
  • [37] The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitus
    Michelle L. O’Donoghue
    Eri T. Kato
    Ofri Mosenzon
    Sabina A. Murphy
    Avivit Cahn
    Marisol Herrera
    Tsvetalina Tankova
    Alena Šmahelová
    Piera Merlini
    Ingrid Gause-Nilsson
    Anna Maria Langkilde
    Darren K. McGuire
    John P. H. Wilding
    Larry A. Leiter
    Deepak L. Bhatt
    Itamar Raz
    Marc S. Sabatine
    Stephen D. Wiviott
    Diabetologia, 2021, 64 : 1226 - 1234
  • [38] The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitus
    O'Donoghue, Michelle L.
    Kato, Eri T.
    Mosenzon, Ofri
    Murphy, Sabina A.
    Cahn, Avivit
    Herrera, Marisol
    Tankova, Tsvetalina
    Smahelova, Alena
    Merlini, Piera
    Gause-Nilsson, Ingrid
    Langkilde, Anna Maria
    McGuire, Darren K.
    Wilding, John P. H.
    Leiter, Larry A.
    Bhatt, Deepak L.
    Raz, Itamar
    Sabatine, Marc S.
    Wiviott, Stephen D.
    DIABETOLOGIA, 2021, 64 (06) : 1226 - 1234
  • [39] Diabetes Management in Hospitalized Patients with Type 2 Diabetes (T2D) during Fasting Periods
    Rainer, Raphael
    Elsayed, Hesham
    Aberer, Felix
    Beck, Peter
    Pieber, Thomas R.
    Donsa, Klaus
    Plank, Johannes
    Mader, Julia K.
    DIABETES, 2018, 67
  • [40] Body Composition Methods in Adults with Type 2 Diabetes or at Risk for T2D: a Clinical Review
    Sneed, Nadia Markie
    Morrison, Shannon A.
    CURRENT DIABETES REPORTS, 2021, 21 (05)
12345